2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid

C13H19BrO7 — CID 11257124

IUPAC2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid
SMILESCC1(C)O[C@H]2[C@@H](O1)[C@@H](C(Br)C(=O)O)O[C@@H]1OC(C)(C)O[C@@H]12
InChIInChI=1S/C13H19BrO7/c1-12(2)18-7-6(5(14)10(15)16)17-11-9(8(7)19-12)20-13(3,4)21-11/h5-9,11H,1-4H3,(H,15,16)/t5?,6-,7+,8+,9-,11-/m1/s1
InChIKeyIICUVFAZGSJQOA-BRYMXRFFSA-N
MW367.19 g/mol
LogP1.23
Rot. Bonds2

About 2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid

2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid (PubChem CID 11257124) has the molecular formula C13H19BrO7 and a molecular weight of 367.19 g/mol. Its IUPAC name is 2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid.

Molecular Properties

Compound Name2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid
PubChem CID11257124
Molecular FormulaC13H19BrO7
Molecular Weight367.19 g/mol
Exact Mass366.03
IUPAC Name2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid
SMILESCC1(C)O[C@H]2[C@@H](O1)[C@@H](C(Br)C(=O)O)O[C@@H]1OC(C)(C)O[C@@H]12
InChIInChI=1S/C13H19BrO7/c1-12(2)18-7-6(5(14)10(15)16)17-11-9(8(7)19-12)20-13(3,4)21-11/h5-9,11H,1-4H3,(H,15,16)/t5?,6-,7+,8+,9-,11-/m1/s1
InChIKeyIICUVFAZGSJQOA-BRYMXRFFSA-N
XLogP1.23
TPSA83.45 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds2
Heavy Atoms21
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500367.19
LogP ≤ 51.23
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid?
The IUPAC name of 2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid (CID 11257124) is 2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid.
What is the SMILES notation for 2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid?
The canonical SMILES for 2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid is CC1(C)O[C@H]2[C@@H](O1)[C@@H](C(Br)C(=O)O)O[C@@H]1OC(C)(C)O[C@@H]12.
What is the InChIKey of 2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid?
The InChIKey is IICUVFAZGSJQOA-BRYMXRFFSA-N. The full InChI is InChI=1S/C13H19BrO7/c1-12(2)18-7-6(5(14)10(15)16)17-11-9(8(7)19-12)20-13(3,4)21-11/h5-9,11H,1-4H3,(H,15,16)/t5?,6-,7+,8+,9-,11-/m1/s1.
What are the key properties of 2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid?
2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid has a molecular weight of 367.19 g/mol, XLogP of 1.23, 2 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-bromo-2-[(1S,2R,6R,8S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl]acetic acid is sourced from PubChem (CID 11257124), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).